The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value.

Analyst David Larsen from BTIG maintained a Buy rating on LifeMD (LFMD – Research Report) and keeping the price target at $12.00. David ...

A pharmacist warns that off-brand Ozempic, Zepbound, and other weight loss products carry undisclosed risks for consumers.

Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.

On October 3, 2024, the US Food and Drug Administration (FDA) revised its shortage categorization of tirzepatide, a glucagon-like peptide 1 ...

The dreaded “food noise”—where uncontrollable cravings nudge you to give in—is a common barrier to weight loss.

The wife of country music star Jelly Roll recently shared that she began using tirzepatide, an antidiabetic medication that was granted FDA approval to treat weight loss. But despite just taking a ...